Lombardi Comprehensive Cancer Center at Georgetown — Washington D.C., District of Columbia

Lombardi Comprehensive Cancer Center at Georgetown is a clinical research site located in Washington D.C., District of Columbia, United States 20057.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Lombardi Comprehensive Cancer Center at Georgetown has participated in 1 clinical trials.

Therapeutic areas: Ovarian, Melanoma, Renal.

Sponsors: Mannkind Corporation.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Comprehensive Cancer Center at Georgetown?

Lombardi Comprehensive Cancer Center at Georgetown has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Comprehensive Cancer Center at Georgetown conducted?

Lombardi Comprehensive Cancer Center at Georgetown has 1 clinical trials on record. Their work covers Ovarian, Melanoma, Renal.

Is Lombardi Comprehensive Cancer Center at Georgetown accredited by Crixeo Health?

Lombardi Comprehensive Cancer Center at Georgetown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lombardi Comprehensive Cancer Center at Georgetown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.